167 related articles for article (PubMed ID: 26619150)
1. Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities.
Clark R; Blizzard C; Dickson T
Neurodegener Dis Manag; 2015 Dec; 5(6):511-25. PubMed ID: 26619150
[TBL] [Abstract][Full Text] [Related]
2. Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis.
Khademullah CS; Aqrabawi AJ; Place KM; Dargaei Z; Liang X; Pressey JC; Bedard S; Yang JW; Garand D; Keramidis I; Gasecka A; Côté D; De Koninck Y; Keith J; Zinman L; Robertson J; Kim JC; Woodin MA
Brain; 2020 Mar; 143(3):800-810. PubMed ID: 32203578
[TBL] [Abstract][Full Text] [Related]
3. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
Vucic S; Cheah BC; Kiernan MC
Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
[TBL] [Abstract][Full Text] [Related]
4. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
[TBL] [Abstract][Full Text] [Related]
5. Spinal inhibitory circuits and their role in motor neuron degeneration.
Ramírez-Jarquín UN; Lazo-Gómez R; Tovar-Y-Romo LB; Tapia R
Neuropharmacology; 2014 Jul; 82():101-7. PubMed ID: 24157492
[TBL] [Abstract][Full Text] [Related]
6. Reduced GABAergic inhibition explains cortical hyperexcitability in the wobbler mouse model of ALS.
Nieto-Gonzalez JL; Moser J; Lauritzen M; Schmitt-John T; Jensen K
Cereb Cortex; 2011 Mar; 21(3):625-35. PubMed ID: 20643756
[TBL] [Abstract][Full Text] [Related]
7. Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS.
Park SB; Kiernan MC; Vucic S
Neurotherapeutics; 2017 Jan; 14(1):78-90. PubMed ID: 27878516
[TBL] [Abstract][Full Text] [Related]
8. [Motor nerve hyperexcitability in ALS: its pathophysiology and treatment].
Shibuya K; Misawa S; Kuwabara S
Rinsho Shinkeigaku; 2014; 54(12):1086-8. PubMed ID: 25672715
[TBL] [Abstract][Full Text] [Related]
9. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis.
Zanette G; Tamburin S; Manganotti P; Refatti N; Forgione A; Rizzuto N
J Neurol; 2002 Dec; 249(12):1723-8. PubMed ID: 12529797
[TBL] [Abstract][Full Text] [Related]
10. Cumulative effect of 5 daily sessions of θ burst stimulation on corticospinal excitability in amyotrophic lateral sclerosis.
Munneke MA; Rongen JJ; Overeem S; Schelhaas HJ; Zwarts MJ; Stegeman DF
Muscle Nerve; 2013 Nov; 48(5):733-8. PubMed ID: 23424061
[TBL] [Abstract][Full Text] [Related]
11. Cortical Hyperexcitability in Amyotrophic Lateral Sclerosis: C9orf72 Repeats.
Wainger BJ; Cudkowicz ME
JAMA Neurol; 2015 Nov; 72(11):1235-6. PubMed ID: 26348624
[No Abstract] [Full Text] [Related]
12. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
Vucic S; Kiernan MC
Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
[TBL] [Abstract][Full Text] [Related]
13. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
Kanai K; Kuwabara S; Misawa S; Tamura N; Ogawara K; Nakata M; Sawai S; Hattori T; Bostock H
Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
Fontanilla CV; Wei X; Zhao L; Johnstone B; Pascuzzi RM; Farlow MR; Du Y
Neuroscience; 2012 Mar; 205():185-93. PubMed ID: 22206942
[TBL] [Abstract][Full Text] [Related]
15. Masseter inhibitory reflex in amyotrophic lateral sclerosis.
Shimizu T; Komori T; Kato S; Kawata A; Hayashi H; Hirai S
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Dec; 2(4):189-95. PubMed ID: 11958730
[TBL] [Abstract][Full Text] [Related]
16. Emerging targets and treatments in amyotrophic lateral sclerosis.
Zinman L; Cudkowicz M
Lancet Neurol; 2011 May; 10(5):481-90. PubMed ID: 21511200
[TBL] [Abstract][Full Text] [Related]
17. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
18. Changes in cortically induced inhibition in amyotrophic lateral sclerosis with time.
Attarian S; Pouget J; Schmied A
Muscle Nerve; 2009 Mar; 39(3):310-7. PubMed ID: 19208411
[TBL] [Abstract][Full Text] [Related]
19. Motor evoked potentials (MEPs): evaluation of the different types of responses in amyotrophic lateral sclerosis and primary lateral sclerosis.
Salerno A; Carlander B; Camu W; Georgesco M
Electromyogr Clin Neurophysiol; 1996 Sep; 36(6):361-8. PubMed ID: 8891476
[TBL] [Abstract][Full Text] [Related]
20. Transcranial direct current stimulation does not modulate motor cortex excitability in patients with amyotrophic lateral sclerosis.
Munneke MA; Stegeman DF; Hengeveld YA; Rongen JJ; Schelhaas HJ; Zwarts MJ
Muscle Nerve; 2011 Jul; 44(1):109-14. PubMed ID: 21674525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
